Literature DB >> 7944544

Acquired rectovaginal fistula.

E S Borgstein1, R L Broadhead.   

Abstract

Nine girls presented with an acquired rectovaginal fistula shortly after birth. All mothers tested were seropositive for HIV. It is suggested that an acquired rectovaginal fistula is an early manifestation of HIV infection in girls.

Entities:  

Mesh：

Year:  1994        PMID： 7944544      PMCID： PMC1029955          DOI： 10.1136/adc.71.2.165

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

Review 1.  Surgical pathology of HIV infection: lessons from Africa.

Authors:  A C Bayley
Journal:  Br J Surg       Date:  1990-08       Impact factor: 6.939

Review 2.  Human immunodeficiency virus infection in children.

Authors:  J Falloon; J Eddy; L Wiener; P A Pizzo
Journal:  J Pediatr       Date:  1989-01       Impact factor: 4.406

Review 3.  Pediatric AIDS.

Authors:  A Rubinstein
Journal:  Curr Probl Pediatr       Date:  1986-07

4.  AIDS in children: a review of the clinical, epidemiologic and public health aspects.

Authors:  M F Rogers
Journal:  Pediatr Infect Dis       Date:  1985 May-Jun
  4 in total
  4 in total

1.  Acquired rectovaginal fistula.

Authors:  M J Oliver
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

2.  Pseudomonal rectovaginal abscesses in HIV infection.

Authors:  M Sharland; J Peake; E G Davies
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

3.  Infantile vulvar abscess with a normal anus: a suspicious sign of rectovestibular fistula.

Authors:  Seong Min Kim; Youn Joon Park; Soo Min Ahn; Jung Tak Oh; Seok Joo Han
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

4.  Comparison of in-hospital morbidity and mortality in HIV-infected and uninfected children after surgery.

Authors:  Jonathan S Karpelowsky; Alastair J W Millar; Nelleke van der Graaf; Guido van Bogerijen; Heather J Zar
Journal:  Pediatr Surg Int       Date:  2012-08-26       Impact factor: 1.827
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.